Monday, 20 June 2016

Global Dental Market is expected to cross the figure of USD 50 Billion by 2020

In the present century, rising aging populace coupled with growing understanding for high esthetics, oral health care and superior dental treatments have enhanced the development of the global dental market. Moreover growing disposable income, rising edentulous populace and increasing figure of retired baby boomers have also impacted the expansion of the sector in positive direction.  Global Dental Market is a muti-Billion dollar industry, by the end 2020 this market is expected to cross the figure of USD 50 Billion.

Moreover improvement in the division of dental biomaterials and tissue regenerative material has make possible for the dentists to suggest more natural and longtime dental support and solutions. Dentists are now enlightening their patients regarding dental products and latest accessible expertise to improve customer awareness. Demand for dental products and services will remain healthy due to increasing frequency of cosmetic treatments, rising figure of dental implants, novel products that decrease patient uneasiness and improve health awareness. 

Phone: +1-678-302-0700 (USA) +91-120-421-9822 (India)

Tuesday, 7 June 2016

Chinese MICE tourists visiting Russia will increase by almost 1 Million by 2020

In European region, countries particularly, Russia, Germany and France are among the top business travel destinations for Chinese MICE travelers. Italy, Switzerland and United Kingdom are also emerging as a destination of choice for Chinese MICE travelers.For MICE, China's outbound travel tends to split into two groups. Huge groups choose cities or countries nearby like Hong Kong and Macau. In contrast, small and VIP groups choose long–haul destinations.

Russia receives the highest number of Chinese tourists followed by Germany and France respectively. We expect that Chinese MICE tourists visiting Russia will increase by almost 1 Million by 2020. France received close to double number of Chinese MICE tourists in 2014 compared to it received tourists in 2010.Chinese MICE tourists visiting Switzerland has almost tripled in the year 2014 as compared to 2010 figure.

For more info:
Phone: +1-678-302-0700 (USA) +91-120-421-9822 (India)

Monday, 23 May 2016

2 Million Electric Cars were sold by 2015

Global Electric car numbers has increased in a phenomenal rate. By the end of 2015 the number of global electric car was slightly less than 2 Million.Hybrid Electric Vehicle controls the highest market share, but it is losing its market share year on year. Plug in Hybrid vehicle and Battery Electric Vehicles will gain most of the volume shares. Electric car is the future of automobile industry. Several car companies are trying to get a foothold into this market.

But the credit goes to Toyota for being the first company to bring Hybrid vehicle for commercial sales to the market. Toyota had launched Toyota Prius in 1997, later on company provided the option of “Hybrid Synergy Drive” and Lexus versions as “Lexus Hybrid Drive” on the smaller cars like Camry. Lexus division also produced some hybrid luxury cars.Another automobile company Renault has launched four battery electric vehicles (BEVs), Renault Fluence Z.E., Renault Zoe, Renault Kangoo Z.E. utility van and the Renault Twizy urban quadri cycle between 2011 and 2013

Friday, 13 May 2016

Autonomous car Market is expected to grow with 50% CAGR Globally

In the recent years autonomous car technologies have advanced to very encouraging levels and is expected to become commercially in few years. In few years new car models are using features such as parking assist system, adaptive cruise control etc. Self-Driving cars provides increased road safety and lesser accidents. In recent years various automobile companies like Mercedes-Benz, Nissan and General Motors etc. are working on autonomous cars.Even electric car companies like Tesla S have introduced some of the “autopilot” features in 2015, and Google leader in the autonomous car industry is expected to tie-up with some automobile manufactures to bring its self-driving car in the market.

Global – Forecast for Sales of Self Driving/Automatic Car (Million), 2020 – 2035 

Source:Frost & Sullivan, BI Intelligence, IHS, Renub Research Analysis

As per an analysis from 2020 to 2025 the autonomous car is expected to grow with a CAGR of merely 5%, but from 2025 to 2035 it is expected to grow with a CAGR of nearly 50%. North America and China will together control more than 50% market share in autonomous car market. Europe will also account for a significant amount of market share globally.

For more info:
Phone: +1-678-302-0700 (USA) +91-120-421-9822 (India)

Thursday, 7 April 2016

Genetic Testing Perspective in the Global Scenario

Genetic testing is the most sophisticated techniques used to test for genetic disorders. It involves direct assessment of the DNA molecule. Genetic testing, which recently has been transforming itself from service to product driven market is expected to provide momentum to diagnostic companies with respect to development of their procedures. The market is expected to increase for screening the newborns, diagnosing rare and fatal disorders, and predicting the chances of incidence of diseases, such as Huntington. Genetic tests for newborn screening are likely to increase hugely over the upcoming years. In addition, with go forward in genetic testing procedures, tests would be paying attention on early finding of Alzheimer disease, hemochromatosis, breast cancer, colorectal cancer, diabetes in young citizens, and rare forms of amyotrophic side sclerosis.

Genetic testing discovers finest cancer treatment for specific patients. Advancements in genetic testing, together with hereditarily engineered drugs, are likely to aid in tailoring personalized medication for specific races, persons, and families. Genetic counseling services are on the rise, specifically in the US. Presently, there are around 2,780 certified genetic counselors operating in United States. Direct-to-Consumer genetic testing is expected to open new avenues, for companies looking for areas to further develops their range of screening tests. The United States and Europe together account for about 83% of the global genetic testing market.

Predictive Breast Cancer Gene Testing Market
Predictive gene testing is utilized to detect disease or disorder inherited by examines gene mutations coupled with particular hereditary disease. Predictive gene testing is also known as presymptomatic testing due to the fact that this test is executed even before the early signs of the disease or disorder are observed and thus enable determining person’s risk of difficulty disease or disorder. Predictive breast cancer gene testing is presented to discover risk of breast cancer in an individual having a family history of breast cancer. 

Early discovery of breast cancer make possible for the absolute cure of the patient and saving pretentious breast of the patient. In view of the benefit of early finding of breast cancer, Government have in progress taking plans to stretch alertness about breast cancer and the early detection techniques available in their respective region. Increasing breast cancer rates worldwide is another major cause of concern for governments worldwide to spotlight on vigilance programs to decrease the morbidity rate breast cancer.

Factors such as growing incidences of breast cancer worldwide, Government are paying attention on dipping the morbidity rate of breast cancer and spreading responsiveness about the available treatments in respective countries are driving the predictive breast genetic testing market .  However, expiration of Myriad Genetics’s patent, BRCAnalysis gene test in coming years will allow the entry of many market players in this field.

Tuesday, 29 March 2016

Central Nervous System (CNS) Drugs Market Overview

Central Nervous System (CNS) drugs market consists of drugs used for the treatment of diseases have an effect on the brain such as epilepsy, Parkinson’s disease, depression and anxiety. Epilepsy is a chronic brain disorder characterized by frequent abductions. Parkinson’s disease is a degenerative CNS disorder associated with symptoms of rigidity and tremor. According to Parkinson’s disease Foundation nearly 7-10 Million people are affected with Parkinson’s disease across the globe. These diseases affect by the neurodegeneration, autoimmune disorders and trauma.

Increase in CNS diseases prevalence rates due to aging population, introduction of new class of drugs and increased expenditure on healthcare are the driving force for the growth of CNS Drugs market. In recent years, there is no drug available to cure Alzheimer’s disease, the available medicines only treat the austerity of symptoms and develop the quality of life to some extent. There are lots of companies such as Eli Lilly, Baxter International and Novartis AG are investing vigorously in research and development in order to accelerate the treatment of Alzheimer’s disease. Geographically, North America grabs the major share of the total market of CNS disorders. Europe and Asia Pacific holds the second and third highest market share. Asia Pacific is the boon for the lots of companies because of high prevalence of diseases such as epilepsy, Parkinson disease and Alzheimer’s disease.

 Some of the key players operating in the market for CNS disorders are Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis AG, Sanofi, Merck & Co., Abbott Laboratories, Eli Lilly, UCB, Bristol-Meyers Squibb Co. and Astellas Pharma, Inc.

Alzheimer’s disease – A boon for the Pharmaceuticals Industry

Alzheimer’s disease drug market is on the decline stage.  Since 2003, there is not any single drug launched in the market to prevent or cure it. However, all the current available drugs are going to be generic in 1-2 years. There are high unmet medical needs. The pharmaceuticals companies are looking for the opportunity which has lots of potential in the Alzheimer’s disease market. If the Pharmaceuticals companies have succeeded, they will be in a position to command premium prices and tap the existing opportunity.

From the year 2009 Alzheimer’s disease drug market is declining and it is expected to fall till 2016. But with the expected launch of some Alzheimer’s drugs from the year 2017 onwards, Alzheimer’s disease drug market is expected to revive in the coming years. However due to absence of exact potential drugs there will always remain a huge Unmet Alzheimer’s Drug Market. Alzheimer’s disease drug market declined year on year from the year 2009. It is expected to fall till 2016. Alzheimer’s disease drug market is expected to revive from the year 2017 onwards. There will always remain a huge Unmet Alzheimer’s Drug Market.